Neoadjuvant TherapyChemotherapy, AdjuvantEsophagectomyChemoradiotherapy, AdjuvantAntineoplastic Combined Chemotherapy ProtocolsRadiotherapy, AdjuvantTreatment OutcomeRectal NeoplasmsBreast NeoplasmsCombined Modality TherapyNeoplasm StagingEsophageal NeoplasmsFluorouracilAdenocarcinomaTaxoidsDisease-Free SurvivalEpirubicinChemoradiotherapyPrognosisDoxorubicinAntineoplastic AgentsCisplatinSarcomaSurvival RatePancreatic NeoplasmsNeoplasm Recurrence, LocalDeoxycytidineSurvival AnalysisCyclophosphamideReceptor, erbB-2Retrospective StudiesAntibodies, Monoclonal, HumanizedPancreaticoduodenectomyPancreatectomyPaclitaxelNomogramsNeoplasm, ResidualAntineoplastic Agents, HormonalLymphatic MetastasisPositron-Emission TomographyFluorodeoxyglucose F18Drug Administration ScheduleOrganoplatinum CompoundsProspective StudiesFollow-Up StudiesKaplan-Meier EstimateCarcinoma, Squamous CellEsophagogastric JunctionPredictive Value of TestsPreoperative CareReceptors, EstrogenTumor Markers, BiologicalTomography, X-Ray ComputedTumor BurdenLeucovorinMastectomy, SegmentalAnthracyclinesCarcinoma, Pancreatic DuctalRadiopharmaceuticalsProstatectomySoft Tissue NeoplasmsTime FactorsCarcinomaCystectomyNeoplasm MetastasisMultivariate AnalysisAntibodies, MonoclonalBiomarkers, PharmacologicalVinblastineImmunohistochemistryLung NeoplasmsCarcinoma, Ductal, BreastMuscle NeoplasmsReceptors, ProgesteroneMethotrexateOsteosarcomaBridged CompoundsCarcinoma, LobularRemission InductionCarboplatinNitrilesKi-67 AntigenIfosfamideMastectomyRisk FactorsUrinary Bladder NeoplasmsAndrogen Antagonists